| Code | CSB-MP023991HUj2 |
| Abbreviation | Recombinant Human TNFSF14 protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
TNFSF14 (LIGHT) plays a critical role in T cell costimulation and tumor microenvironment remodeling through engagement of HVEM and LTβR, making it a key target in immuno-oncology research. This recombinant human TNFSF14 (aa 74–240), expressed as an N-terminal hFc-Myc-tagged protein in mammalian cells, demonstrates robust receptor binding with an EC50 of 45.44–53.29 ng/ml against immobilized TNFRSF14 in functional ELISA, supporting its use in antibody development, receptor-blocking assays, and as a coating antigen or positive control in cytokine detection platforms. The confirmed signaling competence provides a suitable basis for NF-κB pathway activation studies, T cell costimulation assays, and in vivo tumor biology models where LIGHT-HVEM axis modulation is under investigation. Endotoxin levels below 1.0 EU/μg minimize LPS-driven artifacts in primary immune cell experiments, while purity exceeding 85% by SDS-PAGE satisfies criteria typical for cell-based functional assays.
Applications : Binding assay/Protein-protein interaction
Review: We conducted LSPR after receiving the product and the results showed that TNFSF14 had a good affinity with the ligand BCMA. It was subsequently used as standard, antibodies were screened, and the ELISA experimental curve showed good linearity, achieving ideal results. We have purchased several batches, and the experimental repeatability is quite good. The protein is stable and can maintain high activity for a long time. The COA introduction is very detailed and can be downloaded directly from the official website, which is very convenient!
By Anonymous